Established in late 2018, VisionX is led by an elite team of ophthalmology and optometry industry veterans with substantial China and global experiences in product development and commercialization. China’s market demand for innovative eye care products increases significantly over the years. VisionX’s broad and robust portfolio is well positioned for gaining shares in the fast-growing markets of myopia management and ocular surface vision problems. Backed by top-tier investors with solid track record in healthcare investment in China and worldwide, VisionX aims to provide a lifetime of healthy vision for consumers in China with its differentiated total solutions.